Showing 65,181 - 65,200 results of 101,677 for search '(( 5 ((c decrease) OR (a decrease)) ) OR ( 5 ((teer decrease) OR (mean decrease)) ))', query time: 1.76s Refine Results
  1. 65181

    Data_Sheet_1_Raw Milk Microbiota Modifications as Affected by Chlorine Usage for Cleaning Procedures: The Trentingrana PDO Case.pdf by Paola Cremonesi (5892311)

    Published 2020
    “…Cheese volatilome analysis showed a slight decrease in lipolysis during C period in the inner part of the cheese wheel. …”
  2. 65182

    Formation of <sup>1</sup>O<sub>2</sub> and H<sub>2</sub>O<sub>2</sub> during experiments in 2006, 2008 and 2009. by Stefanie P. Glaeser (542828)

    Published 2014
    “…A. 12<sup>nd</sup> July 2006: a clear sky during the afternoon led to a steady decrease in [<sup>1</sup>O<sub>2</sub>]<sub>SS</sub> concentrations from noon to late afternoon. …”
  3. 65183

    MSC<sup>hUCB1</sup> express neural specific markers suggesting neural differentiation. by Murni Tio (197880)

    Published 2013
    “…The MAPK pathway is down-regulated as a consequence of differentiation as shown by decreasing levels of P-ERK1/2 correlated to increasing length of differentiation. …”
  4. 65184

    Characterization of the sexual development of deletion mutants for spore-enriched proteins. by Mingwei Huang (788799)

    Published 2015
    “…Panels show the periphery of a spot of a cross on V8 plate for 24h at 25°C. …”
  5. 65185

    Presentation1_Defining the Dynamic Regulation of O-GlcNAc Proteome in the Mouse Cortex---the O-GlcNAcylation of Synaptic and Trafficking Proteins Related to Neurodegenerative Disea... by Van N Huynh (11498971)

    Published 2021
    “…Pharmacological increase of protein O-GlcNAcylation by Thiamet G (TG) has been shown to decrease tau phosphorylation and neurotoxicity, and proposed as a therapy in Alzheimer’s disease (AD). …”
  6. 65186

    Table2_Defining the Dynamic Regulation of O-GlcNAc Proteome in the Mouse Cortex---the O-GlcNAcylation of Synaptic and Trafficking Proteins Related to Neurodegenerative Diseases.xls... by Van N Huynh (11498971)

    Published 2021
    “…Pharmacological increase of protein O-GlcNAcylation by Thiamet G (TG) has been shown to decrease tau phosphorylation and neurotoxicity, and proposed as a therapy in Alzheimer’s disease (AD). …”
  7. 65187

    Image1_High-mobility group box 1 protein, receptor for advanced glycation end products and nucleosomes increases after marathon.TIF by Julia Schoenfeld (11136603)

    Published 2023
    “…</p><p>Conclusion: Prolonged and strenuous exercise increases markers of ICD immediately post-race, followed by a decrease within 72 h. An acute marathon event results in transient alterations of ICD, we assume that this is not solely driven by myocyte damages.…”
  8. 65188

    Impact of Environment and Social Gradient on <em>Leptospira</em> Infection in Urban Slums by Renato B. Reis (90436)

    Published 2008
    “…An increase of US$1 per day in per capita household income was associated with an 11% (95% CI 5%–18%) decrease in infection risk.</p><h3>Conclusions</h3><p>Deficiencies in the sanitation infrastructure where slum inhabitants reside were found to be environmental sources of <em>Leptospira</em> transmission. …”
  9. 65189

    Failure of Miltefosine Treatment for Visceral Leishmaniasis in Children and Men in South-East Asia by Bart Ostyn (194715)

    Published 2014
    “…</p><p>Conclusions</p><p>Young age and male gender were associated with increased risk of VL relapse after miltefosine, suggesting that the mechanism of relapse is mainly host-related i.e. immunological factors and/or drug exposure (pharmacokinetics). The observed decrease in efficacy of miltefosine may be explained by the inclusion of younger patients compared to the earlier clinical trials, rather than by a decreased susceptibility of the parasite to miltefosine. …”
  10. 65190

    Chronic Intermittent Hypoxia Is Independently Associated with Reduced Postoperative Opioid Consumption in Bariatric Patients Suffering from Sleep-Disordered Breathing by Alparslan Turan (2336)

    Published 2015
    “…Percentage of total sleep time spent at SaO<sub>2</sub> < 90% was inversely associated with total postoperative opioid consumption; a 5-%- absolute increase in the former would relatively decrease median opioid consumption by 16% (98.75% CI: 2% to 28%, P = 0.006). …”
  11. 65191

    Table4_Defining the Dynamic Regulation of O-GlcNAc Proteome in the Mouse Cortex---the O-GlcNAcylation of Synaptic and Trafficking Proteins Related to Neurodegenerative Diseases.xls... by Van N Huynh (11498971)

    Published 2021
    “…Pharmacological increase of protein O-GlcNAcylation by Thiamet G (TG) has been shown to decrease tau phosphorylation and neurotoxicity, and proposed as a therapy in Alzheimer’s disease (AD). …”
  12. 65192

    Failure of Miltefosine Treatment for Visceral Leishmaniasis in Children and Men in South-East Asia by Bart Ostyn (194715)

    Published 2014
    “…</p><p>Conclusions</p><p>Young age and male gender were associated with increased risk of VL relapse after miltefosine, suggesting that the mechanism of relapse is mainly host-related i.e. immunological factors and/or drug exposure (pharmacokinetics). The observed decrease in efficacy of miltefosine may be explained by the inclusion of younger patients compared to the earlier clinical trials, rather than by a decreased susceptibility of the parasite to miltefosine. …”
  13. 65193

    Sprouty4 is epigenetically upregulated in human colorectal cancer by Alexei J. Stuckel (14132689)

    Published 2022
    “…Three loci within the promoter region of <i>SPRY4</i> were evaluated for 5mC levels in CRC using the combined bisulfite restriction analysis. …”
  14. 65194

    Sex hormone stimulation of CRISPR-modified HepG2 cells alters alpha-1 antitrypsin production by Emma Leacy (11872358)

    Published 2025
    “…</p><p dir="ltr"><b>Results:</b> Both hormones significantly reduced intracellular AAT (Figure 1A), even at low concentrations. There was also a dose-dependent decrease in AAT release, particularly in oestrogen-treated cells (Figure 1C). …”
  15. 65195

    DataSheet1_Defining the Dynamic Regulation of O-GlcNAc Proteome in the Mouse Cortex---the O-GlcNAcylation of Synaptic and Trafficking Proteins Related to Neurodegenerative Diseases... by Van N Huynh (11498971)

    Published 2021
    “…Pharmacological increase of protein O-GlcNAcylation by Thiamet G (TG) has been shown to decrease tau phosphorylation and neurotoxicity, and proposed as a therapy in Alzheimer’s disease (AD). …”
  16. 65196

    Table3_Defining the Dynamic Regulation of O-GlcNAc Proteome in the Mouse Cortex---the O-GlcNAcylation of Synaptic and Trafficking Proteins Related to Neurodegenerative Diseases.xls... by Van N Huynh (11498971)

    Published 2021
    “…Pharmacological increase of protein O-GlcNAcylation by Thiamet G (TG) has been shown to decrease tau phosphorylation and neurotoxicity, and proposed as a therapy in Alzheimer’s disease (AD). …”
  17. 65197

    Table1_Defining the Dynamic Regulation of O-GlcNAc Proteome in the Mouse Cortex---the O-GlcNAcylation of Synaptic and Trafficking Proteins Related to Neurodegenerative Diseases.xls... by Van N Huynh (11498971)

    Published 2021
    “…Pharmacological increase of protein O-GlcNAcylation by Thiamet G (TG) has been shown to decrease tau phosphorylation and neurotoxicity, and proposed as a therapy in Alzheimer’s disease (AD). …”
  18. 65198

    AR activation causes cell cycle arrest and senescence in PC3 cells. by Yelena Mirochnik (179447)

    Published 2012
    “…(<b>E</b>) Senescent cells were counted on the digital images of 5 random fields using Image Tool 3.00 software (UTHSCSA); means of three independent experiments with S.D.M. are shown. …”
  19. 65199

    Mechanosensitive response of the cardiac tube in control (<i>y</i>,<i>w</i>; <i>CS</i> ×1029-Gal4) larvae. by Sébastien Sénatore (80383)

    Published 2010
    “…When the larva attempts to crawl, the frequency decreases (b) and a 2 sec-cardiac arrest in diastole occurs during the maximal shortening of the larva (c). …”
  20. 65200

    Quantification of fused MSC by flow cytometry. by Jonathan Ferrand (190140)

    Published 2011
    “…Fused cells expressed ESA (99%±0.0 of positive cells); CD90 (89.5%±0.6) and CD105 (69.5%±1.9). <b>C/</b> Expression of epithelial and mesenchymal markers was assessed at day 9, 15 and 17. …”